dysmenorrhea
Conditions
Interventions
the group of low-level light treatment:Patients is treatment with a PDT-V system,take NASIDS if necessary
Oral contraceptives group:Take contraceptive for treatment,take NASIDS if necessary
Observation control group:Observation and take NASIDS if necessary
Sponsors
Department of Gynecology, the First Hospital of Shanxi Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. Aged > 20 years; 2. The menstrual cycle is 25 to 38 days, and the total dysmenorrhea index is more than 3 points in the baseline measurement or empirical score (the sum of the two sub-scores describing the severity of dysmenorrhea and the use of painkillers). 3. If the patient has a history of smoking and smokes more than 15 cigarettes a day, the age should be less than 35 years old. 4. Clinical symptoms of dysmenorrhea:lower abdominal pain before, during or after menstrual period, radioactive pain in back or thigh, accompanied by nausea, vomiting, headache, fatigue, dizziness, diarrhea, abdominal swelling, depression and other systemic symptoms; 5. All patients agreed to use condom contraceptives during the trial.
Exclusion criteria
Exclusion criteria: 1. Aged > 40 years; 2. BMI > 30 kg/m2; 3. Cervical Cytology examination abnormal need to be further diagnosis and treatment, patients is diagnosed with abnormal uterine bleeding. 4. Patients have a history of allergies to oral contraceptives, non-steroidal anti-inflammatory drugs, and light therapyantiphospholipid antibody syndrome.Contraindications for oral contraceptives and non-steroidal anti-inflammatory drugs, including hypertension, valvular disease or coronary heart disease, cerebrovascular disease, thrombophlebitis, thrombosis, abnormal liver function, including liver disease during pregnancy, severe renal insufficiency, diabetes, dyslipidemia, estrogen-dependent tumors, migraine, otosclerosis, thyroid dysfunction, depression, etc., And active or past peptic ulcers. 5. There are organic diseases requiring surgery, such as ovarian chocolate cyst, submucous uterine myoma, reproductive organ malformation, uterine cavity cervical adhesion and so on. 6. Patients with Endometriosis who underwent surgical treatment within 2 months of the baseline observation. Patients who have taken oral contraceptives in the past 2 months. 7. The diameter of chocolate cyst in ovary is more than 10 cm. 8. Or any disease, or the use of any drug, may hinder the conduct of research or interpretation of the results, can not be included in the study. 9. Patients who are pregnant, breast-feeding, or who wish to become pregnant within a predetermined period of treatment are also not included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;CMSS; | — |
Countries
China
Contacts
Public ContactYe Zhao
The First Hospital of Shanxi Medical University
Outcome results
None listed